Cargando…

1060. Evaluation of ALT at Sustained Virologic Response (SVR) in Patients with Treated Hepatitis C Virus (HCV) Infection

BACKGROUND: With the advent of directly acting antiviral agents, HCV cure rates exceed 90% in real world studies with an excellent safety profile, but viral load tests of cure are expensive and may limit access to treatment, especially in resource-limited settings. Elevated alanine aminotransferase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Theppote, Amanda, Nelson, Amy, Stafford, Kristen A, Wilson, Eleanor, Kottilil, Shyam, Kaplan, Roman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776739/ http://dx.doi.org/10.1093/ofid/ofaa439.1246

Ejemplares similares

Peripheral PD-1(+) T Cells Co-expressing Inhibitory Receptors Predict SVR With Ultra Short Duration DAA Therapy in HCV Infection
por: Romani, Sara, et al.
Publicado: (2019)

1067. Interferon-free Hepatitis C Treatment Increases Surrogates of Cardiovascular Disease Risk in Black Veterans
por: Mathur, Poonam, et al.
Publicado: (2020)

1069. Loss to follow-up does not impact SVR for HCV infection
por: Kottilil, Sita K, et al.
Publicado: (2020)

Sustained Virologic Response for Chronic Hepatitis C Infection After 27 Days of Treatment with Sofosbuvir and Ribavirin
por: Meissner, Eric G., et al.
Publicado: (2014)

IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection
por: Chen, J-Y, et al.
Publicado: (2011)

Ultra-Rapid Virological Response, Young Age, Low γ-GT/ALT-Ratio, and Absence of Steatosis Identify a Subgroup of HCV Genotype 3 Patients Who Achieve SVR with IFN-α(2a) Monotherapy
por: Amanzada, Ahmad, et al.
Publicado: (2011)

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection
por: Orr, Cody, et al.
Publicado: (2020)

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR
por: Yeh, Ming-Lun, et al.
Publicado: (2021)

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals
por: Lin, Chuan-Pin, et al.
Publicado: (2021)

Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirin
por: Nakayama, Masahiko, et al.
Publicado: (2015)

Prevalence and predictors of abnormal alanine aminotransferase in patients with HCV who have achieved SVR
por: Chadha, Nikita, et al.
Publicado: (2022)

Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
por: Vigón, Lorena, et al.
Publicado: (2019)

The relationship of histologic activity to serum ALT, HCV genotype and HCV RNA titers in chronic hepatitis C.
por: Lee, Y. S., et al.
Publicado: (2001)

Effect of HIV infection-related factors on SVR rate in HCV treatment in HIV-infected patients
por: Kravchenko, Alexey, et al.
Publicado: (2014)

Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal
por: Ghosh, Alip, et al.
Publicado: (2020)

Effects of Achieving SVR on Clinical Characteristics and Surgical Outcomes in Patients Who Developed Early-Stage HCV-Related Hepatocellular Carcinoma and Received Curative Resection: Preoperative versus Postoperative SVR
por: Hsu, Po-Yao, et al.
Publicado: (2022)

SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China
por: Li, Yanhua, et al.
Publicado: (2017)

HCV Integrated Care: A Randomized Trial to Increase Treatment Initiation and SVR with Direct Acting Antivirals
por: Groessl, Erik J., et al.
Publicado: (2017)

Quadruple Therapy Offers High SVR Rates in Patients with HCV Genotype 4 with Previous Treatment Failure
por: Abo-amer, Yousry Esam-Eldin, et al.
Publicado: (2020)

Dynamics of APRI and FIB-4 in HCV cirrhotic patients who achieved SVR after DAA therapy
por: Leuştean, Anca, et al.
Publicado: (2021)

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord
por: Smit, Colette, et al.
Publicado: (2015)

Detection of hepatitis C virus (HCV) RNA in the peripheral blood mononuclear cells of HCV-infected patients following sustained virologic response
por: Khattab, Mahmoud A., et al.
Publicado: (2022)

Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis
por: Mangia, Alessandra, et al.
Publicado: (2018)

1060 ejercicios y juegos de natación
por: Lanuza Arús, Francesc de
Publicado: (1993)

1060 ejercicios y juegos de natación
por: Lanuza Arús, Francesc de
Publicado: (1997)

Interferon Alpha Therapy in Patients with Chronic Type C Hepatitis: Changes of Serum ALT, Anti-HCV & HCV-RNA
por: Cho, Ho Jun, et al.
Publicado: (1992)

1057. CpG-adjuvanted Hepatitis B vaccination improves seroprotection rates in Veterans with HIV
por: Deming, Meagan, et al.
Publicado: (2020)

Frequency and predictive factors of minimal hepatic encephalopathy before and after sustained virological response in HCV cirrhosis
por: Piedade, Juliana, et al.
Publicado: (2022)

Influence of Genetic Variants on Disease Regression and Outcomes in HCV-Related Advanced Chronic Liver Disease after SVR
por: Semmler, Georg, et al.
Publicado: (2021)

Dynamic Changes in Non-Invasive Markers of Liver Fibrosis Are Predictors of Liver Events after SVR in HCV Patients
por: Fernández-Alvarez, Paula, et al.
Publicado: (2023)

Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis
por: Radhakrishnan, Kavita, et al.
Publicado: (2019)

Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
por: Labarga, P, et al.
Publicado: (2010)

1060. Risk Factors for Recurrent Staphylococcus aureus Bacteremia
por: Choi, Seong-Ho, et al.
Publicado: (2018)

Molecular Virology of Hepatitis C Virus (HCV): 2006 Update
por: Brass, Volker, et al.
Publicado: (2006)

Durable Sustained Virologic Response After Oral Directly Acting Antiviral Therapy Despite Immunosuppressive Treatment
por: Hahn, Katherine J., et al.
Publicado: (2015)

SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin
por: Thorlund, Kristian, et al.
Publicado: (2014)

Persistent Hepatic Inflammation Plays a Role in Hepatocellular Carcinoma After Sustained Virological Response in Patients with HCV Infection
por: Nirei, Kazushige, et al.
Publicado: (2018)

Natural Killer KIR3DS1 Is Closely Associated with HCV Viral Clearance and Sustained Virological Response in HIV/HCV Patients
por: Rivero-Juarez, Antonio, et al.
Publicado: (2013)

The Relationship between Virological Characteristics of Hepatitis C Virus (HCV) and Reactivity to the Regional Specific Proteins of HCV(*)
por: Yoon, Seung Kew, et al.
Publicado: (2000)

Virologic Tools for HCV Drug Resistance Testing
por: Fourati, Slim, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a9pfpnaoc6k3klmdmt162ghakc